Skip to main content
. 2020 Apr 22;8(4):e17108. doi: 10.2196/17108

Table 1.

Quality indicators from baseline, implementation, and follow-up periods averaged across the 3 weeks from each period.

Long-term care unit QIa 1b, % (n/N) QI 2c, % (n/N) QI 3d, % (n/N) QI 4e, % (n/N) QI 5f, % (n/N)
Unit A





Baseline g 0 (0.00/31.67)h 73 (2.67/3.67) 9 (0.33/3.67) 0 (0.00/3.67)

Tablet app 100 (30.67/30.67) 100 (3.00/3.00) 100 (3.00/3.00) 0 (0.00/0.00)

Tablet app (continued) 100 (1.00/1.00) 100 (29.67/29.67) 100 (1.00/1.00) 100 (1.00/1.00) 0 (0.00/0.00)

Follow-up 0 (0.00/1.00) 2 (0.67/30.67) 100 (1.50/1.50) 100 (1.50/1.50) 67 (1.00/1.50)
Unit B





Baseline 0 (0.00/1.50) 9 (2.33/25.67) 91 (3.33/3.67) 0 (0.00/3.67) 46 (1.67/3.67)

Paper-and-pencil 100 (18.00/18.00) 100 (1.00/1.00) 100 (1.00/1.00) 0 (0.00/1.00)

Tablet app 100 (1.00/1.00) 100 (19.33/19.33) 100 (1.00/1.00) 100 (1.00/1.00) 0 (0.00/1.00)

Follow-up 15 (3.33/22.00)
Unit C





Baseline 0 (0.00/39.00) 100 (8.00/8.00) 4 (0.33/8.00) 8 (0.67/8.00)

Paper-and-pencil 100 (39.00/39.00) 100 (5.00/5.00) 100 (5.00/5.00) 0 (0.00/5.00)

Paper-and-pencil (continued) 100 (38.33/38.33) 100 (2.00/2.00) 100 (2.00/2.00) 0 (0.00/2.00)

Follow-up 0 (0.00/39.00) 100 (2.00/2.00) 100 (2.00/2.00) 0 (0.00/2.00)
Unit D





Baseline 0 (0.00/1.00) 0 (0.00/38.33) 100 (1.50/1.50) 100 (1.50/1.50) 100 (1.50/1.50)

Paper-and-pencil 98 (38.33/39.00) 100 (1.00/1.00) 100 (1.00/1.00) 0 (0.00/1.00)

Tablet app 100 (38.33/38.33) 100 (1.50/1.50) 100 (1.50/1.50) 0 (0.00/1.50)

Follow-up 0 (0.00/39.00) 100 (1.00/1.00) 100 (1.00/1.00) 0 (0.00/1.00)
Unit E





Baseline 0 (0.00/2.00) 5 (4.67/90.00) 93 (4.33/4.67) 14 (0.67/4.67) 0 (0.00/4.67)

Paper-and-pencil 0 (0.00/4.33) 65 (58.33/90.00) 100 (1.33/1.33) 50 (0.67/1.33) 100 (1.33/1.33)

Tablet app 0 (0.00/3.50) 10 (8.67/90.00)

Follow-up 0 (0.00/2.00) 8 (7.33/90.00)
Unit F





Baseline 0 (0.00/30.00) 100 (2.00/2.00) 100 (2.00/2.00) 100 (2.00/2.00)

Tablet app 100 (30.00/30.00) 100 (4.00/4.00) 100 (4.00/4.00) 100 (4.00/4.00)

Paper-and-pencil 100 (30.00/30.00) 100 (4.33/4.33) 100 (4.33/4.33) 100 (4.33/4.33)

Follow-up 100 (1.00/1.00) 4 (1.33/30.00) 100 (1.67/1.67) 100 (1.67/1.67) 100 (1.67/1.67)
Unit G





Baseline 100 (1.00/1.00) 0 (0.00/45.00) 84 (9.00/10.67) 0 (0.00/10.67) 69 (7.33/10.67)

Paper-and-pencil 51 (23.00/45.00) 8 (0.67/8.33) 4 (0.33/8.33) 0 (0.00/8.33)

Paper-and-pencil (continued) 100 (1.00/1.00) 29 (13.00/45.00) 0 (0.00/3.00) 0 (0.00/3.00) 0 (0.00/3.00)

Follow-up 16 (7.33/45.00) 30 (1.00/3.33) 10 (0.33/3.33) 10 (0.33/3.33)

aQI: quality indicator.

bNumber and percentage of new residents assessed using the PACSLAC-II on admission averaged across the total number of weeks from each period.

cNumber and percentage of current residents assessed using the PACSLAC-II at least once per week averaged across the total number of weeks from each period.

dNumber and percentage of residents with moderate-to-severe pain with a treatment plan within 24 hours averaged across the total number of weeks from each period.

eNumber and percentage of residents with moderate-to-severe pain with a reassessment within 24 hours averaged across the total number of weeks from each period.

fNumber and percentage of residents with moderate-to-severe pain assessed for side effects within 24 hours averaged across the total number of weeks from each period.

gThe symbol "—" indicates that there were no new admissions or no residents with moderate-to-severe pain during for that period.

hThe n and N values in this table have decimals as they represent total numbers collected on a weekly basis averaged over a period of 3 weeks.